-M Eileen Dolan Researcher Activity Profile

Research Author Detailed Information 

M Eileen Dolan Publication Rate By Year

M Eileen Dolan has published 15 paper(s) in 2007, 2 paper(s) in 2008, for a total of 17 research publications in total.

M Eileen Me Dolan Author Information

LAST NAME: dolan

FIRST NAME: M Eileen

INITIALS: me

AFFILIATION:

Papers

M Eileen Dolan's Publication Record

1. Role of O6-methylguanine-DNA methyltransferase in protecting from alkylating agent-induced toxicity and mutations in mice. Year Published: 2007
Committee on Cancer Biology, The University of Chicago, 5841 S. Maryland Avenue, Chicago, IL 60637, USA.
2. Molecular mechanisms of resistance and toxicity associated with platinating agents. Year Published: 2007
Department of Medicine, Committee on Clinical Pharmacology and Pharmacogenomics, University of Chicago, 5841 S. Maryland Avenue, Box MC2115, Section of Hem-Onc, Chicago, IL 60637, United States.
3. Phase I trial of polifeprosan 20 with carmustine implant plus continuous infusion of intravenous O6-benzylguanine in adults with recurrent malignant glioma: new approaches to brain tumor therapy CNS consortium trial. Year Published: 2007
New Approaches to Brain Tumor Therapy CNS Consortium, Baltimore, MD, USA.
4. The pharmacogenetics research network: from SNP discovery to clinical drug response. Year Published: 2007
Department of Biopharmaceutical Sciences, University of California San Francisco, San Francisco, California, USA. kathy.giacomini@ucsf.edu
5. Mapping genes that contribute to daunorubicin-induced cytotoxicity. Year Published: 2007
Department of Medicine, The University of Chicago, Chicago, Illinois 60637, USA.
6. A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity. Year Published: 2007
Section of Hematology-Oncology, Biostatistics Consulting Laboratory, Department of Health Studies, University of Chicago, Chicago, IL 60637, USA.
7. Inhibition of nuclear factor-kappaB activity by temozolomide involves O6-methylguanine induced inhibition of p65 DNA binding. Year Published: 2007
Section of Neurosurgery, Department of Surgery, The University of Chicago Hospitals, 5841 South Maryland Avenue, Chicago, IL 60637, USA. byamini@surgery.bsd.uchicago.edu
8. Role of MGMT in protecting against cyclophosphamide-induced toxicity in cells and animals. Year Published: 2007
Committee on Cancer Biology, The University of Chicago, 5841 S. Maryland Avenue, Chicago, IL 60637, USA.
9. Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach. Year Published: 2007
Department of Medicine, University of Chicago, Chicago, IL 60637, USA.
10. Genome scan implicates adhesion biological pathways in secondary leukemia. Year Published: 2007
Department of Hematology-Oncology, St Jude Children's Research Hospital, Memphis, TN 38105, USA.
11. Utilization of fluoroethene as a surrogate for aerobic vinyl chloride transformation. Year Published: 2007
School of Chemical, Biological and Environmental Engineering, 101 Gleeson Hall, Oregon State University, Corvallis 97331, USA.
12. Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group Study. Year Published: 2007
Texas Children's Cancer Center/Baylor College of Medicine, Houston, TX 77030, USA. tmhorton@txccc.org
13. Role of MGMT in protecting against cyclophosphamide-induced toxicity in cells and animals. Year Published: 2007
Committee on Cancer Biology, The University of Chicago, 5841 S. Maryland Avenue, Chicago, IL 60637, USA.
14. Utilization of fluoroethene as a surrogate for aerobic vinyl chloride transformation. Year Published: 2007
School of Chemical, Biological and Environmental Engineering, 101 Gleeson Hall, Oregon State University, Corvallis 97331, USA.
15. A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity. Year Published: 2007
Section of Hematology-Oncology, Biostatistics Consulting Laboratory, Department of Health Studies, University of Chicago, Chicago, IL 60637, USA.
16. Susceptibility loci involved in cisplatin-induced cytotoxicity and apoptosis. Year Published: 2008
Department of Human Genetics, University of Chicago, Chicago Illinois 60637, USA.
17. Evaluation of genetic variation contributing to differences in gene expression between populations. Year Published: 2008
Department of Medicine, The University of Chicago, Chicago, IL 60637, USA.